| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 06/23/2011 | US20110152278 Synthesis and anti-proliferative effect of benzimidazole derivatives |
| 06/23/2011 | US20110152271 Compositions and methods for ophthalmic delivery of nasal decongestants |
| 06/23/2011 | US20110152260 Indazole derivatives as modulators of interleukin-1 receptor-associated kinase |
| 06/23/2011 | US20110152251 Compounds for modulating tlr2 |
| 06/23/2011 | US20110152250 Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor and uses thereof |
| 06/23/2011 | US20110152246 Novel inhibitors of hepatitis c virus replication |
| 06/23/2011 | US20110152243 Novel thienopyrrole compounds |
| 06/23/2011 | US20110152241 Novel compounds as receptor modulators with therapeutic utility |
| 06/23/2011 | US20110152237 Chemical Compounds |
| 06/23/2011 | US20110152236 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 06/23/2011 | US20110152232 Sulfonamide compounds and uses thereof |
| 06/23/2011 | US20110152095 Novel herbicides |
| 06/23/2011 | US20110152084 N-(1,2,5-oxadiazol-3-yl)benzamides and their use as herbicides |
| 06/23/2011 | US20110150834 Crth2 modulators |
| 06/23/2011 | CA2784830A1 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof |
| 06/23/2011 | CA2784662A1 Hepatitis c virus inhibitors |
| 06/23/2011 | CA2784528A1 Pyrrolidine carboxylic acid derivatives, pharmaceutical composition and methods for use in treating metabolic disorders as agonists of g-protein coupled receptor 43 (gpr43) |
| 06/23/2011 | CA2784075A1 Inhibitors of sphingosine kinase |
| 06/23/2011 | CA2782574A1 3-(indolyl)- or 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment |
| 06/23/2011 | CA2781495A1 Pyrrolidine derivatives |
| 06/22/2011 | EP2336123A2 Heterocyclic compound as protein kinase inhibitor |
| 06/22/2011 | EP2336122A1 1-pyrimidinyl- or 1-pyridinyl-2-amino benzimidazole derivatives and related compounds as inhibitors of protein kinases for the treatment of cancer |
| 06/22/2011 | EP2336121A1 Fungicide n-cycloalkyl-carboxamide, thiocarboxamide and n-substituted-carboximidamide derivatives |
| 06/22/2011 | EP2336109A1 Novel pyrrolinone derivative and medicinal composition containing same |
| 06/22/2011 | EP2335701A1 Heterocyclic aspartyl protease inhibitors |
| 06/22/2011 | EP2335700A1 Hepatitis C virus polymerase inhibitors with a heterobicylic structure |
| 06/22/2011 | EP2334666A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 06/22/2011 | EP2334665A1 Modulators for amyloid beta |
| 06/22/2011 | EP2334663A1 Imidazole and triazole compounds, use thereof and agents containing said compounds |
| 06/22/2011 | EP2334652A1 1h-benz imidazole-5-carboxamides as anti-inflammatory agents |
| 06/22/2011 | EP2334651A2 Dual-acting antihypertensive agents |
| 06/22/2011 | EP2334646A2 Substituted benzamides as cannabinoid receptor ligands |
| 06/22/2011 | EP2334643A1 Phenethylamide derivatives and their heterocyclic analogues |
| 06/22/2011 | EP2334637A1 Novel potassium channel blockers |
| 06/22/2011 | EP2102157B1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives |
| 06/22/2011 | EP2091924B1 Pyrimidine derivatives and their use as pesticides |
| 06/22/2011 | EP1748985B1 Cyclic amide derivatives, and their production and use as antithrombotic agents |
| 06/22/2011 | EP1546162B1 Luminescence-based methods and probes for measuring cytochrome p450 activity |
| 06/22/2011 | CN1845734B Benzimidazole derivatives and their use as protein kinases inhibitors |
| 06/22/2011 | CN102105465A Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof |
| 06/22/2011 | CN102105464A Wnt protein signalling inhibitors |
| 06/22/2011 | CN102105462A Amidophenoxyindazoles useful as inhibitors of C-MET |
| 06/22/2011 | CN102105460A Piperazine compounds with herbicidal effect |
| 06/22/2011 | CN102105459A 3,4-diarylpyrazoles as protein kinase inhibitors |
| 06/22/2011 | CN102105457A 5-demethoxyfumagillol and derivatives thereof |
| 06/22/2011 | CN102105453A Therapeutic agent for chronic renal failure |
| 06/22/2011 | CN102105452A Substituted carbinol compound having cyclic linker |
| 06/22/2011 | CN102105451A Glucokinase activators |
| 06/22/2011 | CN102105437A Adamantyl diamide derivatives and uses of same |
| 06/22/2011 | CN102101858A Preparation method of ramosetron derivatives and applications thereof |
| 06/22/2011 | CN101633645B N3 alkylated benzimidazole derivatives as mek inhibitors |
| 06/22/2011 | CN101570512B Curcumin substituted pyrazole derivatives, and preparation method and uses thereof |
| 06/22/2011 | CN101115742B Heterocycle derivatives as histone deacetylase (hdac) inhibitors |
| 06/22/2011 | CN101006055B 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase iepsilon |
| 06/21/2011 | USRE42477 Carboxylic acid derivatives, their preparation and use |
| 06/21/2011 | US7964724 Chiral cis-imidazolines |
| 06/21/2011 | US7964723 And practical process for exclusively producing (S)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido-[1,2,3,de][1,4]benzoxazine-6-carboxylic acid hemihydrate |
| 06/21/2011 | US7964622 Indole acetic acid derivatives and their use as pharmaceutical agents |
| 06/21/2011 | US7964606 Therapeutic agents useful for treating pain |
| 06/21/2011 | US7964601 Agonist or antgonist and binders and inversion of agonist |
| 06/21/2011 | US7964592 2,4-di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 06/21/2011 | US7964531 3-phenoxy-4-pyridazinol derivatives and herbicidal composition containing the same |
| 06/21/2011 | CA2649403C Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators |
| 06/21/2011 | CA2507707C 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors |
| 06/21/2011 | CA2495386C Protein kinase inhibitors and uses thereof |
| 06/21/2011 | CA2494771C 3-aminocarbonyl-substituted benzoylpyrazolones |
| 06/21/2011 | CA2483303C Cinnamic acid amides |
| 06/21/2011 | CA2473468C Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes |
| 06/21/2011 | CA2442114C N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor |
| 06/21/2011 | CA2427046C A process for making polyaziridines |
| 06/21/2011 | CA2359115C Acyl derivatives which treat vla-4 related disorders |
| 06/16/2011 | WO2011072275A2 Agents and methods for treating ischemic and other diseases |
| 06/16/2011 | WO2011071565A1 Tgr5 agonists |
| 06/16/2011 | WO2011071314A2 Processes for preparing crystalline forms a and b of ilaprazole and process for converting the crystalline forms |
| 06/16/2011 | WO2011071255A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 06/16/2011 | WO2011071095A1 Benzamide compound |
| 06/16/2011 | WO2011070039A1 Spiro indole - cyclopropane indolinones useful as ampk modulators |
| 06/16/2011 | WO2011069952A1 Novel cationic 4-aminoindoles, dye composition comprising a cationic 4-aminoindole, processes therefor and uses thereof |
| 06/16/2011 | WO2011069951A1 Imidazolidinedione derivatives |
| 06/16/2011 | WO2011039735A3 Compounds with ddx3 inhibitory activity and uses thereof |
| 06/16/2011 | WO2011022509A3 Substituted benzoazepines as toll-like receptor modulators |
| 06/16/2011 | WO2011021726A3 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation |
| 06/16/2011 | WO2008075205A3 Improved process for the preparation of voriconazole |
| 06/16/2011 | WO2008004100A3 Therapeutic compounds |
| 06/16/2011 | US20110144351 2,2'-disubstituted dipyrrin compounds, synthesis thereof and methods of use thereof |
| 06/16/2011 | US20110144334 Isoxazoline-substituted benzamide compound and pesticide |
| 06/16/2011 | US20110144332 Pyrazole compounds that modulate hsp90 activity |
| 06/16/2011 | US20110144331 Cinnoline Compounds for the Treatment of Anxiety, Cognitive and Mood Disorders |
| 06/16/2011 | US20110144330 2,4-Pyrimidinediamine Compounds and their Uses |
| 06/16/2011 | US20110144242 Thermoreversibly crosslinked elastic bituminous composition |
| 06/16/2011 | US20110144179 Substituted Heterocyclic Mercaptosulfonamide Metalloprotease Inhibitors |
| 06/16/2011 | US20110144174 Deuterium-enriched odansetron |
| 06/16/2011 | US20110144170 Fc RECEPTOR MODULATING COMPOUNDS AND COMPOSITIONS |
| 06/16/2011 | US20110144169 Inhibitors of cellular necrosis |
| 06/16/2011 | US20110144129 3-Aminocyclopentanecarboxamides as Chemokine Receptor Agonists |
| 06/16/2011 | US20110144126 Compounds useful for inhibiting chk1 |
| 06/16/2011 | US20110144116 DERIVATIVES OF (BRIDGED PIPERAZINYL)-1-ALKANONE AND USE THEREOF AS p75 INHIBITORS |
| 06/16/2011 | US20110144112 Apoptosis promoters |
| 06/16/2011 | US20110144110 Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents |
| 06/16/2011 | US20110144106 Novel cyclopropane indolinone derivatives |